Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-07-01Clinical Trial Results: Computerized Intervention Targeting the Error-Related Negativity and Balance N1 in Anxious Children [NA]
A completed clinical trial evaluating a computerized intervention targeting error-related negativity and balance N1 in anxious children; res…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Brain Response Associated With Parent-based Treatment for Childhood Anxiety Disorders [NA]
A completed Yale-sponsored clinical trial examined brain responses associated with a parent-based treatment for childhood anxiety disorders,…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Miles for Mental Health [NA]
Miles for Mental Health is a registered clinical trial that is NOT_YET_RECRUITING, investigating generalized anxiety disorder and depressive…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Development and Multicenter Validation of an AI-Based Remote Photoplethysmography (rPPG) Facial Scan for Multimodal Health Assessment
This trial update covers the development and multicenter validation of an AI-based remote photoplethysmography (rPPG) facial scan for multim…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Enhancing Health in Rural Populations: Music as Therapy [NA]
Northern Arizona University is conducting a clinical trial to evaluate music therapy for stress, generalized anxiety, chronic pain, and depr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-04-15FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for Buspirone hydrochloride from Oxford Pharmaceuticals, LLC, finalizing regulatory approval for thi…
-
FDA approval · 2026-04-09FDA Approved: DULOXETINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves a supplemental application for duloxetine hydrochloride as a generic product from Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS other · 2026-04-07Clinical Trial Update: P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety [Phase 3]
Phase 3b short-term study of CTN in patients with ADHD and comorbid anxiety is ongoing but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device in Adult Patients With Moderate to Severe Generalized Anxiety Disorder [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of the Aurora Digital Medical Device in adults with generalized anxiety disorder i…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated in Oncology. Multicenter Study.
Multicenter study validating a rapid screening tool for anxiety and depressive disorders in children, adolescents, and young adults treated …
-
FDA approval · 2026-03-27FDA Approved: ESCITALOPRAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for a generic escitalopram product (ANDA 078169).
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Transdiagnostic Metacognitive Therapy Compared to Disorder-Specific Cognitive-Behavioral Therapy for Anxiety Disorders [NA]
A clinical trial compares transdiagnostic metacognitive therapy with disorder-specific cognitive-behavioral therapy for anxiety disorders an…
-
FDA approval · 2026-03-26FDA Approved: PAROXETINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved Alembic Pharmaceuticals Inc.'s supplemental application for paroxetine (generic). This marks approval of a generic paroxeti…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: RE104 Safety and Efficacy Study in Generalized Anxiety Disorder [Phase 2]
Phase 2 clinical trial RE104 for generalized anxiety disorder is listed as not yet recruiting, evaluating safety and efficacy.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Transdiagnostic Versus Diagnosis-specific Cognitive-behavioral Therapy [NA]
Karolinska Institutet is conducting a trial comparing transdiagnostic cognitive-behavioral therapy with diagnosis-specific CBT across severa…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Mindfulness-Based Psychoeducation With Substance Use and Anxiety Disorders
This ClinicalTrials.gov update notes that a trial evaluating mindfulness-based psychoeducation for substance use disorder and generalized an…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: CES for the Treatment of GAD in Young Adults [NA]
The clinical trial update reports that a study evaluating cranial electrotherapy stimulation for generalized anxiety disorder in young adult…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder [Phase 2]
A Phase 2a trial evaluating SYT-510 in Generalized Anxiety Disorder is underway, assessing efficacy, safety, tolerability, and pharmacokinet…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama) [Phase 3]
A Phase 3 trial named Panorama evaluating MM120 for generalized anxiety disorder is currently recruiting, sponsored by Definium Therapeutics…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Improving Attentional and Cognitive Control in the Psychological Treatment of Intrusive Thoughts [NA]
A completed ClinicalTrials.gov update from Massachusetts General Hospital reports results posted for a trial evaluating attentional and cogn…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: LHC-CIDI-5 in Hong Kong
A clinical trial update indicates that LHC-CIDI-5 is currently recruiting in Hong Kong for multiple psychiatric conditions, including major …
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Pharmacokinetic Study of Buagafuran Capsules in Participants With Hepatic Impairment and Normal Hepatic Function [Phase 1]
Phase 1 pharmacokinetic study of Buagafuran capsules in participants with hepatic impairment and those with normal hepatic function to infor…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder [Phase 3]
A Phase 3 trial assessing cannabidiol-assisted learning for Generalized Anxiety Disorder is currently recruiting, sponsored by Wayne State U…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric Disorders [NA]
This update notes the completion of a study evaluating transcranial direct current stimulation (tDCS) across multiple psychiatric disorders.…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Group Cognitive Evolutionary Therapy for Depression [NA]
This document reports an ongoing clinical trial on Group Cognitive Evolutionary Therapy for depression and anxiety, currently active but not…